Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 2
1964 2
1966 2
1967 2
1974 1
1976 2
1977 3
1978 1
1979 2
1981 5
1982 7
1983 12
1984 6
1985 8
1986 13
1987 14
1988 9
1989 12
1990 4
1991 11
1992 14
1993 9
1994 17
1995 12
1996 10
1997 12
1998 21
1999 12
2000 13
2001 23
2002 23
2003 16
2004 25
2005 22
2006 19
2007 23
2008 29
2009 22
2010 29
2011 31
2012 20
2013 24
2014 27
2015 25
2016 32
2017 16
2018 26
2019 25
2020 31
2021 45
2022 74
2023 10
Text availability
Article attribute
Article type
Publication date

Search Results

798 results
Results by year
Filters applied: . Clear all
Page 1
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.
Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, Simoneau CR, Ciling A, Khalid MM, Sreekumar B, Chen PY, Kumar GR, Montano M, Gascon R, Tsou CL, Garcia-Knight MA, Sotomayor-Gonzalez A, Servellita V, Gliwa A, Nguyen J, Silva I, Milbes B, Kojima N, Hess V, Shacreaw M, Lopez L, Brobeck M, Turner F, Soveg FW, George AF, Fang X, Maishan M, Matthay M, Morris MK, Wadford D, Hanson C, Greene WC, Andino R, Spraggon L, Roan NR, Chiu CY, Doudna JA, Ott M. Suryawanshi RK, et al. Among authors: kojima n. Nature. 2022 Jul;607(7918):351-355. doi: 10.1038/s41586-022-04865-0. Epub 2022 May 18. Nature. 2022. PMID: 35584773 Free PMC article.
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.
Syed AM, Ciling A, Khalid MM, Sreekumar B, Chen PY, Kumar GR, Silva I, Milbes B, Kojima N, Hess V, Shacreaw M, Lopez L, Brobeck M, Turner F, Spraggon L, Taha TY, Tabata T, Chen IP, Ott M, Doudna JA. Syed AM, et al. Among authors: kojima n. medRxiv. 2022 Jan 2:2021.12.20.21268048. doi: 10.1101/2021.12.20.21268048. Preprint. medRxiv. 2022. PMID: 34981067 Free PMC article. Updated.
Sitosterolemia.
Tada H, Kojima N, Takamura M, Kawashiri MA. Tada H, et al. Among authors: kojima n. Adv Clin Chem. 2022;110:145-169. doi: 10.1016/bs.acc.2022.06.006. Epub 2022 Aug 9. Adv Clin Chem. 2022. PMID: 36210074
Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination.
Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, Simoneau CR, Ciling A, Khalid MM, Sreekumar B, Chen PY, Kumar GR, Montano M, Garcia-Knight MA, Sotomayor-Gonzalez A, Servellita V, Gliwa A, Nguyen J, Silva I, Milbes B, Kojima N, Hess V, Shacreaw M, Lopez L, Brobeck M, Turner F, Soveg FW, George AF, Fang X, Maishan M, Matthay M, Greene WC, Andino R, Spraggon L, Roan NR, Chiu CY, Doudna J, Ott M. Suryawanshi RK, et al. Among authors: kojima n. medRxiv. 2022 Feb 9:2022.01.13.22269243. doi: 10.1101/2022.01.13.22269243. Preprint. medRxiv. 2022. PMID: 35075459 Free PMC article. Updated.
The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
Tsutsuura M, Moriyama H, Kojima N, Mizukami Y, Tashiro S, Osa S, Enoki Y, Taguchi K, Oda K, Fujii S, Takahashi Y, Hamada Y, Kimura T, Takesue Y, Matsumoto K. Tsutsuura M, et al. Among authors: kojima n. BMC Infect Dis. 2021 Feb 6;21(1):153. doi: 10.1186/s12879-021-05858-6. BMC Infect Dis. 2021. PMID: 33549035 Free PMC article.
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages.
Bohn T, Rapp S, Luther N, Klein M, Bruehl TJ, Kojima N, Aranda Lopez P, Hahlbrock J, Muth S, Endo S, Pektor S, Brand A, Renner K, Popp V, Gerlach K, Vogel D, Lueckel C, Arnold-Schild D, Pouyssegur J, Kreutz M, Huber M, Koenig J, Weigmann B, Probst HC, von Stebut E, Becker C, Schild H, Schmitt E, Bopp T. Bohn T, et al. Among authors: kojima n. Nat Immunol. 2018 Dec;19(12):1319-1329. doi: 10.1038/s41590-018-0226-8. Epub 2018 Nov 5. Nat Immunol. 2018. PMID: 30397348
Is the Patient Infected with SARS-CoV-2?
Klausner JD, Kojima N, Butler-Wu SM. Klausner JD, et al. Among authors: kojima n. J Clin Microbiol. 2021 Mar 19;59(4):e00147-21. doi: 10.1128/JCM.00147-21. Print 2021 Mar 19. J Clin Microbiol. 2021. PMID: 33500362 Free PMC article.
Notes on syphilis vaccine development.
Kojima N, Konda KA, Klausner JD. Kojima N, et al. Front Immunol. 2022 Jul 28;13:952284. doi: 10.3389/fimmu.2022.952284. eCollection 2022. Front Immunol. 2022. PMID: 35967432 Free PMC article. Review.
The Covid-19 Vaccine-Development Multiverse.
Kojima N, Turner I, Klausner JD. Kojima N, et al. N Engl J Med. 2021 Feb 18;384(7):681-682. doi: 10.1056/NEJMc2034838. Epub 2021 Jan 27. N Engl J Med. 2021. PMID: 33503338 No abstract available.
798 results